XML 14 R7.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
shares in Thousands, $ in Thousands
 9 Months Ended
Sep. 26, 2025
Sep. 27, 2024
Cash flows from operating activities:    
Net Income (Loss) $ 11,505 $ 1,097
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 8,215 9,171
Asset impairment and related charges 1,637 12,103
Stock-based compensation 23,486 19,587
Foreign currency remeasurement 446 6,513
Deferred income taxes, net (3,120) (2,673)
Provision for excess and obsolete inventories 2,789 3,135
Other 61 435
Changes in operating assets and liabilities:    
Accounts receivable, net 74,121 (31,611)
Inventories (3,944) 6,592
Prepaid expenses and other assets 10,359 (3,489)
Accounts payable (13,785) 1,787
Deferred revenues 1,173 2,062
Other liabilities (17,265) (11,323)
Net cash provided by operating activities 95,678 13,386
Cash flows from investing activities:    
Purchases of property and equipment (8,404) (6,840)
Net cash used in investing activities (8,404) (6,840)
Cash flows from financing activities:    
Proceeds from long-term debt 95,000 115,000
Repayment of convertible debt 0 (115,500)
Repayment of long-term debt and other borrowings (101,897) (4,797)
Payments for debt issuance costs 0 (332)
Repurchase of common stock (65,757) (30,047)
Proceeds from other borrowings 3,835 3,943
Proceeds from common stock issued to employees 5,983 6,628
Taxes paid related to net share settlement of equity awards (3,795) (6,877)
Net cash used in financing activities (66,631) (31,982)
Effect of exchange rate changes on cash and cash equivalents and restricted cash 5,283 (332)
Net increase (decrease) in cash and cash equivalents and restricted cash 25,926 (25,768)
Cash and cash equivalents and restricted cash at beginning of period 101,789 84,269
Cash and cash equivalents and restricted cash at end of period 127,715 58,501
Cash and cash equivalents and restricted cash at end of period    
Cash and cash equivalents 127,376 58,174
Restricted cash included in other current assets 339 327
Total cash, cash equivalents and restricted cash as shown in the condensed consolidated statement of cash flows 127,715 58,501
Supplemental cash flow disclosure:    
Income tax payments, net 14,496 12,894
Interest payments, net 2,897 4,363
Supplemental schedule of non-cash investing activities:    
Capital expenditures incurred but not yet paid $ 968 $ 709
Supplemental schedule of non-cash financing activities:    
Shares of common stock issued upon redemption of the 2024 Notes (in shares) 0 4,578